Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.01.2023 | Case report

Epirubicin

Post-embolisation syndrome: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Zhao Z, et al. Treatment Benefits and Side Effects of Transarterial Chemoembolization with Drug-Eluting Bead Microspheres (DEB-TACE) in Hepatocellular Carcinoma Patients with Conventional TACE Resistance: A Retrospective Study. Iranian Journal of Radiology 19 : 1-8, No. 2, 2022. Available from: URL: https://brieflands.com/articles/iranjradiol-110538.pdf Zhao Z, et al. Treatment Benefits and Side Effects of Transarterial Chemoembolization with Drug-Eluting Bead Microspheres (DEB-TACE) in Hepatocellular Carcinoma Patients with Conventional TACE Resistance: A Retrospective Study. Iranian Journal of Radiology 19 : 1-8, No. 2, 2022. Available from: URL: https://​brieflands.​com/​articles/​iranjradiol-110538.​pdf
Metadaten
Titel
Epirubicin
Post-embolisation syndrome: case report
Publikationsdatum
01.01.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-30740-8

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Iron-sucrose

Case report

Meclozine

Case report

Sirolimus

Case report

Tocilizumab